Industry News
Pharmaceutical Industry News
Bristol Myers Squibb has signed…
Bristol Myers Squibb has signed Kasey Keller for a Breyanzi partnership, giving the U.S, Soccer Hall of Famer a platform to discuss how the CD19-directed CAR-T cell therapy blocked the recurrence of his non-Hodgkin lymphoma.
Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices
The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits.
OXB, a U.K.-based cell and gene…
OXB, a U.K.-based cell and gene therapy manufacturer, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs.
In his first investor update as…
In his first investor update as GSK’s CEO, Luke Miels defined a core of his vision for the company’s next chapter: “We need to be more product-centric as a company.”
Amgen has denied a request by the…
Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said Tuesday as it presented quarterly financial results.
Vice and the Crisis of Liberalism
Is there a political prescription for our era of addiction?
Long known for manufacturing…
Long known for manufacturing generics, vaccines and small-molecule drugs, India is attempting to shift its focus, with a big boost from its government. The country will invest 100 billion rupees ($1.1 billion) over the next
Novo Nordisk turned in sales and…
Novo Nordisk turned in sales and profit growth in 2025 amid an intense obesity market rivalry with Eli Lilly. But investor optimism came to a sudden halt Tuesday as the company warned of significant sales
To stir up support for the fight…
To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time.
Charles River Laboratories is…
Charles River Laboratories is continuing its run of layoffs by announcing the closure of its cell therapy contract development and manufacturing organization (CDMO) site in Hanover, Maryland that will cost the company 20 jobs.
As top-selling Keytruda inches…
As top-selling Keytruda inches closer to its 2028 patent cliff, Merck's confidence in sustainable growth for the future is "as high as it's ever been," CEO Robert Davis said on the company's full-year 2025 earnings
La ostarina, el fármaco que está en el centro del dopaje deportivo
El fármaco prometía profundos cambios en tratamientos médicos. Algo inesperado ocurrió en el camino hacia la aprobación de la FDA.
AstraZeneca will have to negotiate…
AstraZeneca will have to negotiate what appears to be a minor speed bump in order to gain clearance in the U.S. for its subcutaneous version of lupus treatment Saphnelo. The FDA has rejected AZ's application
Nanologica, a life sciences…
Nanologica, a life sciences company that makes silica-based peptides for the pharmaceutical industry, acquired CDMO Ardena’s Syntagon manufacturing facility in a stock deal valued at 8.6 million Swedish kroner ($961,000).
A U.K. marketing watchdog has…
A U.K. marketing watchdog has sanctioned Sanofi after ruling its CEO Paul Hudson may have undermined the U.K. government’s vaccine program by making “bold claims” about a procurement choice.
The Key to Managing Tariffs: Be Big and Have the President’s Ear
Several large American manufacturers are thriving despite the threat of higher costs. Smaller ones are struggling.
With Valentine’s Day coming up,…
With Valentine’s Day coming up, AbbVie has love on the brain. Ahead of the holiday, the Big Pharma has unveiled a new campaign focusing on how migraines can impact romantic relationships.
The FDA issued complete response…
The FDA issued complete response letters to Aquestive Therapeutics and Pharming in recent days, resulting in vastly different reactions from the market.
Thermo Fisher is continuing its…
Thermo Fisher is continuing its recent layoff spree with a fresh round of cuts tied to a site it’s shuttering in Franklin, Massachusetts, which currently employs about 200 people.
Amid an outpouring of industry…
Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to reduce the complexities involved in setting up domestic manufacturing plants.